Trial intelligence / Profile preview

DIRECT: Iopromide vs Iodixanol in Renally Impaired Patients

NCT00926562Phase 4Completed

Sponsor
Chinese PLA General Hospital
Start
Feb 2009
Primary completion
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of iopromide in coronary heart disease (CHD), sponsored by Chinese PLA General Hospital. Started Feb 2009; status: completed.

02

Drugs

iopromide
03

Conditions

coronary heart disease (CHD)

Beyond the preview

Go deeper on NCT00926562.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00926562.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call